文献速递神经肿瘤功能神经外科

术前导航经颅磁刺激提高运动功能区高级别胶质瘤全切率:匹配队列研究

Preoperative Navigated Transcranial Magnetic Stimulation Improves Gross Total Resection Rates in Patients with Motor-Eloquent High-Grade Gliomas: A Matched Cohort Study.
PubMed 文献 · Neurosurgery · 2021-01-01

本研究回顾性配对比较术前导航经颅磁刺激(nTMS)引导手术与非nTMS手术各105例运动功能区幕上胶质瘤或转移瘤患者。nTMS组总体全切率显著更高(P=.02),运动功能结局无差异(P=.344);WHO III/IV胶质瘤亚组nTMS组全切率72.3% vs 53.2%(P=.049),运动结局无差异(P=.521)。多因素Cox回归显示WHO III/IV胶质瘤生存延长与全切和年轻相关,与nTMS无关。

要点

  • 术前nTMS提高运动功能区胶质瘤全切率且不损害神经功能。
  • WHO III/IV胶质瘤亚组nTMS组全切率72.3% vs 非nTMS组53.2%。
  • 生存获益与全切和年轻相关,nTMS本身未显示独立生存获益。

核心结论

  • 术前nTMS提高运动功能区幕上胶质瘤全切率且不增加运动功能损害。
  • WHO III/IV胶质瘤中nTMS提高全切率,可能转化为总生存获益。
  • nTMS在潜在生存获益中的价值尚待确定。

研究设计与样本

  • 回顾性配对队列研究,nTMS组105例与非nTMS对照组105例配对比较。
  • 对象为运动功能区幕上胶质瘤或转移瘤手术患者。
  • 评估全切率和运动结局,并对WHO III/IV胶质瘤进行亚组生存分析。

主要发现

  • nTMS组总体全切率显著高于非nTMS组(P=.02)。
  • 总体运动结局两组无差异(P=.344)。
  • 转移瘤亚组全切率和运动结局两组相同。
  • WHO III/IV胶质瘤亚组nTMS组全切率72.3%高于非nTMS组53.2%(P=.049)。
  • WHO III/IV胶质瘤亚组运动结局无差异(P=.521)。

关键数值与推荐

  • 全切率总体比较P=.02,运动结局比较P=.344。
  • WHO III/IV胶质瘤亚组全切率72.3% vs 53.2%(P=.049),运动结局P=.521。
  • 多因素Cox回归显示生存延长与全切和年轻患者年龄显著相关,与nTMS无关。

临床怎么用

  • 对运动功能区胶质瘤术前可行nTMS定位以辅助提高全切率。
  • nTMS引导手术未显示增加运动功能损害风险。
  • WHO III/IV胶质瘤中nTMS提高全切率可能有助于生存获益。

局限性

  • 回顾性研究设计。
  • 样本来自单中心或有限学术中心经验。
  • nTMS对生存获益的价值尚待确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Navigated transcranial magnetic stimulation (nTMS) is an established, noninvasive tool to preoperatively map the motor cortex. Despite encouraging reports from few academic centers with vast nTMS experience, its value for motor-eloquent brain surgery still requires further exploration. OBJECTIVE: To further elucidate the role of preoperative nTMS in motor-eloquent brain surgery. METHODS: Patients who underwent surgery for a motor-eloquent supratentorial glioma or metastasis guided by preoperative nTMS were retrospectively reviewed. The nTMS group (n = 105) was pair-matched to controls (non-nTMS group, n = 105). Gross total resection (GTR) and motor outcome were evaluated. Subgroup analyses including survival analysis for WHO III/IV glioma were performed. RESULTS: GTR was significantly more frequently achieved in the entire nTMS group compared to the non-nTMS group (P = .02). Motor outcome did not differ (P = .344). Bootstrap analysis confirmed these findings. In the metastases subgroup, GTR rates and motor outcomes were equal. In the WHO III/IV glioma subgroup, however, GTR was achieved more frequently in the nTMS group (72.3%) compared to non-nTMS group (53.2%) (P = .049), whereas motor outcomes did not differ (P = .521). In multivariable Cox-regression analysis, prolonged survival in WHO III/IV glioma was significantly associated with achievement of GTR and younger patient age but not nTMS mapping. CONCLUSION: Preoperative nTMS improves GTR rates without jeopardizing neurological function. In WHO III/IV glioma surgery, nTMS increases GTR rates that might translate into a beneficial overall survival. The value of nTMS in the setting of a potential survival benefit remains to be determined.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Hendrix P, Dzierma Y, Burkhardt BW, et al. Preoperative Navigated Transcranial Magnetic Stimulation Improves Gross Total Resection Rates in Patients with Motor-Eloquent High-Grade Gliomas: A Matched Cohort Study. Neurosurgery. 2021. PMID: 33289507. doi:10.1093/neuros/nyaa486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。